JPRN-UMIN000017138已完成未知
Phase II trial of dose dense paclitaxel plus carboplatin in advanced or recurrent uterine corpus cancer - KCOG-G-1301 trial
Kansai Clinical Oncology Group0 个研究点目标入组 48 人开始时间: 2015年4月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1)motor or sensory neuropathy with dysfunction 2) alcoholic hypersensitivity 3)bacterial infection to needtreatment 4) myocardial infarction within 6 months 5) unstable angina 6) poor control diabetes 7) active multiple malignancy 8) Interstitial pneumonia, pulmonary fibrosis 9) Paclitaxel or CBDCA is contra-indicated. 10) HBs-Ag(+) 11) Paralytic or mechanical bowel obstruction 12) History of severe drug-induced hypersensitivity syndrome 13) Any other cases who are regarded as inadequate for study enrollment by investigators.
研究者
相似试验
已完成
2 期
Phase II trial of Combination with Paclitaxel, Carboplatin and Cetuximab (PCE) as a first line treatment in patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and NeckJPRN-UMIN000010507CSPOR-HN 02 executive committee45
已完成
2 期
A randomized phase II study of paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches in patients with stage IV non-squamous-non-small cell lung cancer: NVALT1210029107non-small cell lung cancerNL-OMON36516Stichting NVALT studies222
进行中（未招募）
不适用
A randomized phase II study of paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches in patients with stage IV non-squamous-non-small cell lung cancer: NVALT12 - NVALT12metastatic non-squamous non-small-cell lung cancerMedDRA version: 9.1Level: LLTClassification code 10025055Term: Lung cancer non-small cell stage IVEUCTR2010-022104-50-NLStichting NVALT Studies222
招募中
2 期
Phase 2 study of dose-dense nab-paclitaxel followed by EC as neoadjuvant chemotherapy for HER2-negative breast cancerHER2-negative primary breast cancerJPRN-UMIN000026143Teikyo University School of Medicine50
已完成
不适用
RCT PhaseII trial of Paclitaxel (P) and Carboplatin (C) plus continuous Gemcitabine (G) versus Gemcitabine (G) and Carboplatin (C) plus continuous Gemcitabine in untreated non-small cell lung cancer (NSCLC)on-small cell lung cancerJPRN-UMIN000008252Respiratory, Osaka University Hospital100